Chronic Myelogenous Leukemia
Showing NaN - NaN of 34
Chronic Myelogenous Leukemia Trial in Worldwide (imatinib mesilate, interferon-alpha (INF-a), cytarabine (ARA-C))
Completed
- Chronic Myelogenous Leukemia
- imatinib mesilate
- +2 more
-
Birmingham, Alabama
- +162 more
Aug 7, 2013
Chronic Myelogenous Leukemia, Multiple Myeloma, Non Hodgkin's Lymphoma Trial in Houston (CD8 Depleted Donor Lymphocyte)
Terminated
- Chronic Myelogenous Leukemia
- +4 more
- CD8 Depleted Donor Lymphocyte
-
Houston, TexasUT MD Anderson Cancer Center
Aug 22, 2012
Leukemia, Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in Houston (Interleukin-11 (IL-11 or Neumega))
Completed
- Leukemia
- +2 more
- Interleukin-11 (IL-11 or Neumega)
-
Houston, TexasUT MD Anderson Cancer Center
Feb 17, 2012
Acute Myelogenous Leukemia, Agnogenic Myeloid Metaplasia, Chronic Myelogenous Leukemia Trial in Houston (Imatinib Mesylate
Completed
- Acute Myelogenous Leukemia
- +2 more
- Imatinib Mesylate (Gleevec)
- PTK 787 (vatalanib)
-
Houston, TexasM.D. Anderson Cancer Center
Jan 19, 2012
Chronic Myelogenous Leukemia Trial in Houston (Busulfan, Cyclophosphamide, Imatinib Mesylate)
Completed
- Chronic Myelogenous Leukemia
- Busulfan
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Oct 31, 2011
Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)
Completed
- Chronic Myelogenous Leukemia
-
Birmingham, Alabama
- +69 more
Apr 13, 2011
Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))
Completed
- Chronic Myelogenous Leukemia
- decitabine (5-aza-2'deoxycytidine)
-
Duarte, California
- +7 more
Oct 12, 2009
Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))
Completed
- Chronic Myelogenous Leukemia
- decitabine (5-aza-2'deoxycytidine)
-
Duarte, California
- +7 more
Dec 12, 2007